Supplementary Figure 5: Depletion of PD-1+CD38hi CD8+ T cells results in strong anti-tumor response.

a. Tumor growth of variously treated B16-bearing Rag1–/– mice following transfer of either total or PD-1+CD38+ depleted, in vitro activated CD8+ T cells (with an indicated number of mice per group given in parentheses). b. The full scan of the blot showing the expression of CD38 and β-actin in flow-sorted PD-1+CD38+ T cells transfected either with scrambled RNA (scRNA) or CD38 siRNA.